Dr. Ravi Shah, Ph.D.
Professor , Department of Pharmaceutical Analysis
-
ravi[dot]shah[at]niperahm[dot]ac[dot]in, ravi[dot]shah[at]niperahm[dot]res[dot]in -
079-65181200 -
NIPER Ahmedabad, Opposite Air force Station, Palaj -
Gandhinagar, Gujarat, India - 382355
Research Interest
- Advanced characterization of complex therapeutics, including Oligonucleotides, Protein Drug Conjugates, and polymer-based drug delivery systems for pharmaceutical sameness.
- Proteomics and Biomarker Discovery for understanding disease mechanisms and therapeutic response.
- Preformulation studies, characterization of complex APIs and formulations, investigating and preparing Long-Acting Injectables, Dissolution and IVIVC correlation.
- Characterization of Impurities and NDSRIs through advanced LC-HRMS and NMR.
Experience
- 2024 – Continue
Professor
Department of Pharmaceutical Analysis, NIPER Ahmedabad, Gujarat, India
- 2019 – 2024
Associate Professor
Department of Pharmaceutical Analysis, NIPER Ahmedabad, Gujarat, India
- August 2015 – February 2019
Principal Scientist, Associate Director
AR&D,Integrated Product Development Organization, Dr. Reddy’s Laboratory, Bangalore
- April 2015 - July 2015
Senior Principal Investigator
AR&D Biocon-Bristol Myers Squibb R&D Center, Bangalore
- May 2013 – March 2015
Principal Investigator
AR&D Biocon-Bristol Myers Squibb R&D Center, Bangalore
- April 2011 – April 2013
Research Investigator
AR&D Biocon-Bristol Myers Squibb R&D Center, Bangalore
- Octomber 2010 – March 2011
Associate Scientific Manager
AR&D Biocon-Bristol Myers Squibb R&D Center, Bangalore
- July 2007 – September 2010
PhD Scholar
Department of Pharmaceutical Analysis, NIPER-SAS Nagar, Mohali
Research Grants
- ANRF-CRG (on-going):
Opening New Avenues: Protein-Drug Conjugates for Selective CNS Intervention in Neuroblastoma & Glioblastoma, Utilizing Endogenous Alpha-Synuclein Protein-Chemotherapeutic Complexes - Industrial Project Grants (In total ~ 21)
Patent
- Patent Title: PLGA-Dipeptide complex as biocompatible pharmaceutical excipient composition for control drug release
Application Status: Granted (Patent Number: 568071) - Patent Title: An apparatus and a method for preparing a specimen to conduct a drug excipient compatibility test
Application Status: Granted (Patent Number: 583263) - Patent Title: Cu3(OH)2(MoO4)2-coated g-C3N4 composite material and preparation method thereof
Application Status: Granted (Patent Number: 593578) - Patent Title: Substantially Pure Canagliflozin
PCT Application Published: Patent Number: PCT/IB2016/057286; WO 2017/093949
Achievements
- Poster HILIC HRMS method for MDA more than just biomarker`s
- Oral presentation NBRCOM 2021-crotonaldehyde stress biomarker and its modification to alpha-synuclein causative of Parkinson’s disease
- 8th Prize in oral presentation in 3rd National biomedical research competition- 2021
- Startup Grant under IISC from bio incubation Centre
- Second prize secured in Poster Presentation at International Conference on Recent Trends and Future Opportunities in Pharmaceuticals at NIPER-SAS-Nagar, Punjab held on Nov 10-12, 2022. A cash prize of Rs. 7500 was rewarded
Gallery
